In comparison to ICM, CO use is associated with a modestly reduced rate of AKI with more frequent adverse nonrenal events. In studies that use CO as the primary imaging agent, the average incidence of AKI remained high at 6.2%-supporting the concept that factors other than renal toxicity from ICM may contribute to renal impairment following peripheral angiography. © 2017 Wiley Periodicals, Inc.